Pulmozyme
NDC 50242-100 · Genentech, Inc.
Generic namedornase alfa
Dosage formSOLUTION
RouteRESPIRATORY (INHALATION)
Active ingredient(s)DORNASE ALFA
Strength1 mg/mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Deoxyribonuclease I [CS], Recombinant Human Deoxyribonuclease 1 [EPC], Recombinant Proteins [CS]
Marketing categoryBLA
Packages
50242-100-40 — 5 POUCH in 1 CARTON (50242-100-40) / 6 AMPULE in 1 POUCH (50242-100-39) / 2.5 mL in 1 AMPULE
Billed under HCPCS
J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram Medicare Part B payment limit (ASP + 6%): $56.78